Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13336 | 780 | 31.1 | 68% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
754 | 11793 | MENOPAUSE//HORMONE REPLACEMENT THERAPY//MATURITAS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | WOMENS HEALTH INITIATIVE | Author keyword | 5 | 19% | 3% | 26 |
2 | INTERDISCIPLINARY GRP OSTEOPOROSIS | Address | 3 | 60% | 0% | 3 |
3 | WHI STUDY | Author keyword | 2 | 44% | 1% | 4 |
4 | REPORTED USE | Author keyword | 2 | 67% | 0% | 2 |
5 | REPRESENTATIVE POPULATION SURVEYS | Author keyword | 2 | 67% | 0% | 2 |
6 | REPRODUCTION PHYSIOLOGY | Author keyword | 2 | 67% | 0% | 2 |
7 | PERSONAL USE | Author keyword | 2 | 50% | 0% | 3 |
8 | POSTMENOPAUSAL HORMONE THERAPY | Author keyword | 2 | 14% | 1% | 10 |
9 | MENOPAUSE CLINIC | Author keyword | 1 | 50% | 0% | 2 |
10 | PRESCRIPTION ATTITUDE | Author keyword | 1 | 50% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | WOMENS HEALTH INITIATIVE | 5 | 19% | 3% | 26 | Search WOMENS+HEALTH+INITIATIVE | Search WOMENS+HEALTH+INITIATIVE |
2 | WHI STUDY | 2 | 44% | 1% | 4 | Search WHI+STUDY | Search WHI+STUDY |
3 | REPORTED USE | 2 | 67% | 0% | 2 | Search REPORTED+USE | Search REPORTED+USE |
4 | REPRESENTATIVE POPULATION SURVEYS | 2 | 67% | 0% | 2 | Search REPRESENTATIVE+POPULATION+SURVEYS | Search REPRESENTATIVE+POPULATION+SURVEYS |
5 | REPRODUCTION PHYSIOLOGY | 2 | 67% | 0% | 2 | Search REPRODUCTION+PHYSIOLOGY | Search REPRODUCTION+PHYSIOLOGY |
6 | PERSONAL USE | 2 | 50% | 0% | 3 | Search PERSONAL+USE | Search PERSONAL+USE |
7 | POSTMENOPAUSAL HORMONE THERAPY | 2 | 14% | 1% | 10 | Search POSTMENOPAUSAL+HORMONE+THERAPY | Search POSTMENOPAUSAL+HORMONE+THERAPY |
8 | MENOPAUSE CLINIC | 1 | 50% | 0% | 2 | Search MENOPAUSE+CLINIC | Search MENOPAUSE+CLINIC |
9 | PRESCRIPTION ATTITUDE | 1 | 50% | 0% | 2 | Search PRESCRIPTION+ATTITUDE | Search PRESCRIPTION+ATTITUDE |
10 | MENOPAUSAL HORMONE THERAPY | 1 | 11% | 1% | 8 | Search MENOPAUSAL+HORMONE+THERAPY | Search MENOPAUSAL+HORMONE+THERAPY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PREVENT OSTEOPOROSIS | 18 | 83% | 1% | 10 |
2 | HRT | 11 | 27% | 4% | 35 |
3 | GYNECOLOGISTS | 6 | 19% | 4% | 30 |
4 | NONCONTRACEPTIVE ESTROGENS | 6 | 58% | 1% | 7 |
5 | WHI | 4 | 40% | 1% | 8 |
6 | CLIMACTERIC COMPLAINTS | 3 | 22% | 2% | 14 |
7 | POSTMENOPAUSAL ESTROGEN USE | 3 | 19% | 2% | 14 |
8 | CLIMACTERIC PERIOD | 3 | 60% | 0% | 3 |
9 | UP HERS II | 3 | 14% | 2% | 17 |
10 | POSTMENOPAUSAL ESTROGEN | 2 | 12% | 2% | 18 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Women's perceptions of hormone replacement therapy: risks and benefits (1980-2002). A literature review | 2005 | 13 | 127 | 85% |
Evidence-based assessment of the impact of the WHI on women's health | 2012 | 10 | 31 | 55% |
Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives | 2005 | 37 | 60 | 28% |
WISDOM: history and early demise - was it inevitable? | 2002 | 30 | 3 | 33% |
Making decisions about hormone replacement therapy | 2003 | 48 | 29 | 21% |
Factors related to menopausal symptom management decisions | 2011 | 2 | 18 | 50% |
Women's decision making about the use of hormonal and nonhormonal remedies for the menopausal transition | 2003 | 8 | 24 | 54% |
A REVIEW OF POSTMENOPAUSAL HORMONE-THERAPY RECOMMENDATIONS - POTENTIAL FOR SELECTION BIAS | 1993 | 40 | 29 | 41% |
Defining what is normal at menopause: How women's and clinician's different understandings may lead to a lack of provision for those in most need | 2014 | 0 | 20 | 35% |
Educating patients about the benefits and drawbacks of hormone replacement therapy | 1998 | 8 | 38 | 45% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTERDISCIPLINARY GRP OSTEOPOROSIS | 3 | 60% | 0.4% | 3 |
2 | SAFETY EVALUAT EPIDEMIOL | 1 | 33% | 0.4% | 3 |
3 | MASSACHUSETTS CANC REGISTRY | 1 | 33% | 0.3% | 2 |
4 | HLTH SERV COORDINAT | 1 | 50% | 0.1% | 1 |
5 | HURST RD HLTH | 1 | 50% | 0.1% | 1 |
6 | INSERM CIC802 | 1 | 50% | 0.1% | 1 |
7 | ISPARTA HLTH | 1 | 50% | 0.1% | 1 |
8 | JOSEPH F SULLIVAN | 1 | 50% | 0.1% | 1 |
9 | MED HBEREICH | 1 | 50% | 0.1% | 1 |
10 | MEDCLIN DECIS MAKING PROGRAM | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000258883 | HOT FLASHES//VASOMOTOR SYMPTOMS//HOT FLUSHES |
2 | 0.0000251208 | ENDOMETRIAL SAFETY//TRIMEGESTONE//CAS 53 16 7 |
3 | 0.0000215023 | DANISH NURSE COHORT//EPES EPIDEMIOL//BENIGN PROLIFERATIVE EPITHELIAL DISORDERS OF THE BREAST |
4 | 0.0000182086 | HORMONE REPLACEMENT THERAPY//HORMONE THERAPY//TIMING HYPOTHESIS |
5 | 0.0000085971 | TIBOLONE//TIBOLONE METABOLITES//LIVIAL |
6 | 0.0000066972 | AGE AT MENOPAUSE//AGE AT NATURAL MENOPAUSE//EARLY MENOPAUSE |
7 | 0.0000054449 | CLINICAL JUDGEMENT ANALYSIS//ABDOMINAL COMPLAINTS//JUDGMENT ANALYSIS |
8 | 0.0000049704 | FRAX//OSTEOPOROSIS INTERNATIONAL//WHO ABORATING METAB BONE DIS |
9 | 0.0000047146 | ACADEMIC OBSTETRICS AND GYNECOLOGY//THE MEDICAL PROFESSION//CONSULTATION REFERRAL |
10 | 0.0000041511 | VAGINAL ATROPHY//UROGENITAL ATROPHY//VULVOVAGINAL ATROPHY |